Day One Biopharmaceuticals, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Jeremy Bender
- Full Time Employees
- 181
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 395 Oyster Point Boulevard Brisbane CA United States of America 94080
- IPO Date
- May 27, 2021
- CIK
- 0001845337
- Website
- dayonebio.com
- Similar Companies
- Business
- I did not find any relevant information about the latest major company changes specifically for Day One Biopharmaceuticals, Inc. in the initial search. I will now conduct targeted searches for recent news, partnerships, acquisitions, product launches, or strategic developments related to Day One Biopharmaceuticals, Inc.
Servier completes the acquisition of Day One Biopharmaceuticals
Servier completes the acquisition of Day One Biopharmaceuticals
Servier finalise l'acquisition de Day One Biopharmaceuticals
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High – What’s Next?
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More
Day One Biopharmaceuticals Touts OJEMDA Sales Surge, Sets $225M-$250M 2026 Outlook at TD Cowen
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More
Are DAWN and TALK Obtaining Fair Deals for their Shareholders?
DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)
Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)
DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
Day One Shares Surge After $2.5B Servier Deal
Servier to buy Day One Biopharmaceuticals for total equity value of $2.5 billion
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio